GSK plc (NYSE:GSK)
| 35.99 Delayed Data As of Nov 30 |  +0.005 / +0.01%Today’s Change | 33.20 Today|||52-Week Range 39.74 | +2.43% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 8.6B | 6.1B | 5.2B | 4.9B | |
| Short Term Investment Cash | 2.3B | -1.3B | -1.3B | 649.4M | ||
| Cash & Short Term Investments | 8.9B | 6.4B | 5.4B | 5.0B | ||
| Receivables | Receivables | 8.1B | 7.3B | 8.0B | 8.1B | |
| Inventories | Inventories | 7.0B | 6.3B | 7.5B | 7.0B | |
| Current Assets | Prepaid Expenses | 452.5M | 413.9M | 416.6M | 420.3M | |
| Other Current Assets | 67.8M | 265.7M | 152.9M | 1.1B | ||
| Current Assets | 24.4B | 20.6B | 21.5B | 21.6B | ||
| Total Assets | Property, Plant and Equipment - Gross | 30.4B | 27.3B | 29.4B | 28.6B | |
| Depreciation | -16.2B | -14.0B | -14.7B | -14.6B | ||
| Intangible Assets | 32.2B | 30.6B | 31.5B | 29.3B | ||
| Other Assets | 32.6B | 31.0B | 33.1B | 31.1B | ||
| Total Assets | 78.8B | 73.0B | 76.3B | 74.0B | ||
| Liabilities | Accounts Payable | 4.6B | 4.4B | 4.8B | 4.6B | |
| Short Term Debt | 1.9B | 5.1B | 3.8B | 7.4B | ||
| Accrued Expenses | 6.1B | 6.3B | 7.5B | 9.0B | ||
| Other Current Liabilities | 9.6B | 10.8B | 26.0B | 13.7B | ||
| Other Liabilities | 19.8B | 23.5B | 35.9B | 28.6B | ||
| Total Liabilities | Long Term Debt | 22.6B | 18.1B | 19.3B | 25.8B | |
| Deferred Taxes | -2.0B | -3.0B | -3.2B | -3.5B | ||
| Other Liabilities | 15.6B | 16.9B | 8.6B | 8.5B | ||
| Total Liabilities | 65.7B | 66.9B | 71.5B | 69.3B | ||
| Equity | Minority Interest | -76.3M | -201.9M | -820.3M | -564.0M | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 7.5B | 1.4B | -92.0M | 5.6B | ||
| Total Shareholder Equity | 7.5B | 1.4B | -92.0M | 5.6B | ||
| Share Information | Common Shares Outstanding | 2.4B | 2.4B | 2.4B | 2.5B | |
| Addtl. Info. | No data currently available for this section. | |||||
